Printer Friendly
The Free Library
19,585,946 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

Allergan Announces Corrected Record Date.


IRVINE, Calif.--(BW HealthWire)--Aug. 4, 1999--

Allergan, Inc. (NYSE NYSE

See: New York Stock Exchange
: AGN AGN Again (Amateur Radio)
AGN Active Galactic Nucleus
AGN Acute Glomerulonephritis
AGN Accountants Global Network
AGN Air Gabon (ICAO code) 
) announced that its Board of Directors has declared a second quarter dividend of $0.14 per share, payable September 17, 1999, to stockholders of record on August 27, 1999. Allergan's July 28, 1999, press release incorrectly reported the record date for its second quarter dividend as August 17, 1999.

Allergan, Inc., headquartered in Irvine, California Irvine is an incorporated city in Orange County, California, United States. It is a planned city, mainly developed by the Irvine Company since the 1960s. Formally incorporated on December 28 1971, the 69.7 square mile (180.5 km²) city has a population of 202,079 (as of 2007). , is a technology-driven, global health care company providing eye care and specialty pharmaceutical products worldwide. Allergan develops and commercializes products in the eye care pharmaceutical, ophthalmic surgical device, over-the-counter contact lens contact lens, thin plastic lens worn between the eye and eyelid that may be used instead of eyeglasses. Actors, models, and others wear them for appearance, and athletes use them for safety and convenience.  care, movement disorder, and dermatological markets that deliver value to our customers, satisfy unmet medical needs and improve patients' lives.
COPYRIGHT 1999 Business Wire
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1999, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Publication:Business Wire
Geographic Code:1USA
Date:Aug 4, 1999
Words:117
Previous Article:Chase To Acquire Mellon's Residential Mortgage Business -- Will Become Nation's Largest Servicer And Originator.
Next Article:USI Selects ChannelPoint Internet Exchange to Help Control Insurance Distribution Costs.
Topics:



Related Articles
Allergan and Ligand form new research and development corporation to raise $100 million; File unit offering for $32.5 million.
Record date set for offering of rights to purchase units of Allergan Ligand Retinoids Therapeutic Inc.
Allergan Ligand Retinoid Therapeutics, Inc. Subscription Offering Declared Effective By SEC.
Allergan's William C. Shepherd to Retire, David Pyott Named to Become President and CEO; Dr. Herbert W. Boyer Named New Allergan Chairman.
Allergan Reports First Quarter Results.
Allergan Enters Into Exclusive Distribution Agreement With Surgical Instrument System AG; Allergan to Distribute State-of-the-Art Amadeus...
Vistakon and Allergan Announce Global Alliance to Expand the Contact Lens Market; Collaboration Will Leverage Industry-Leading Products and Expertise.
Allergan Reports Fourth Quarter and Year-End Operating Results.
Allergan, Inc. Exercises Option to Purchase Class A Common Stock of Allergan Specialty Therapeutics, Inc.
Allergan Announces Ratio for Distribution of Common Stock of Advanced Medical Optics.

Terms of use | Copyright © 2012 Farlex, Inc. | Feedback | For webmasters | Submit articles